Regeneron Pharmaceuticals, Inc. (REGN)
733.04
-8.88
(-1.20%)
USD |
NASDAQ |
Jan 16, 16:00
733.50
+0.46
(+0.06%)
After-Hours: 20:00
Regeneron Pharmaceuticals Market Cap: 77.04B for Jan. 16, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Amgen, Inc. | 177.92B |
| Gilead Sciences, Inc. | 154.97B |
| Johnson & Johnson | 526.82B |
| Eli Lilly & Co. | 929.39B |
| Merck & Co., Inc. | 270.12B |
Market Cap Related Metrics
| PE Ratio | 17.55 |
| PS Ratio | 5.670 |
| PEG Ratio | 5.219 |
| Price to Book Value | 2.489 |
| Price to Free Cash Flow | 20.81 |
| Price | 733.04 |
| Earnings Yield | 5.70% |
| PEGY Ratio | 5.219 |
| Operating PE Ratio | 21.09 |
| Normalized PE Ratio | 18.27 |